An Evaluation of Medical Resource Utilisation In Patients With Autosomal Dominant Polycystic Kidney Disease In Europe
Value Health
.
2014 Nov;17(7):A530.
doi: 10.1016/j.jval.2014.08.1680.
Epub 2014 Oct 26.
Authors
J Blais
1
,
H B Krasa
2
,
A Szende
3
,
S Colman
4
,
C Schaefer
5
,
P Dale
6
,
P Robinson
6
,
K O'Reilly
6
Affiliations
1
Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA.
2
Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, MD, USA.
3
Covance, Leeds, UK.
4
Covance Pty Ltd, North Ryde, Australia.
5
Covance, Gaithersburg, MD, USA.
6
Otsuka Pharmaceutical Europe Ltd, Wexham, UK.
PMID:
27201680
DOI:
10.1016/j.jval.2014.08.1680
No abstract available